Skip to main content
Journal of Clinical Biochemistry and Nutrition logoLink to Journal of Clinical Biochemistry and Nutrition
. 2021 Aug 7;70(1):28–32. doi: 10.3164/jcbn.21-59

Acid increases PGE2 in the duodenal mucosa in rats

Tadahiro Fujimura 1, Takashi Kondo 1, Kimiko Kobayashi 2, Shaoqi Duan 1,3, Hirosato Kanda 3, Tomoaki Kono 1, Masashi Fukushima 1, Toshihiko Tomita 1, Tadayuki Oshima 1, Hirokazu Fukui 1, Yoshihito Fujii 4, Takashi Konemura 4, Hiroki Okada 4, Hiroki Yamanaka 2, Yi Dai 3, Koichi Noguchi 2, Hiroto Miwa 1,*
PMCID: PMC8764112  PMID: 35068678

Abstract

Attention has recently been paid to the duodenum as the pathophysiologic center of functional dyspepsia. However, the precise mechanisms of symptom generation remain unknown. We here investigated the effect of acid on duodenal prostaglandin E2 and localization of prostaglandin E2 related receptors. Sprague–Dawley rats were used for this study. Hydrochloric acid was administered in the duodenum, then prostaglandin E2 levels in the duodenum were measured using the ELISA. The expression and localization of prostaglandin receptors (EP1–4) and the mRNAs of prostaglandin synthases were investigated using in situ hybridization histochemistry in duodenal tissue. After acid perfusion, prostaglandin E2 levels in the duodenum significantly increased. EP3 was expressed mainly at the myenteric plexus in the duodenal mucosa, and EP4 at both the epithelial surface and myenteric plexus. Contrary, EP2 was sparsely distributed in the villi and EP1 were not clearly seen on in situ hybridization histochemistry. Prostaglandin-synthetic enzymes were also distributed in the duodenal mucosa. The prostaglandin E2 levels in the duodenum increased after acidification. Prostaglandin E2 receptors and prostaglandin E2-producing enzymes were both observed in rat duodenum. These observations suggest that duodenal prostaglandin E2 possibly play a role in the symptom generation of functional dyspepsia.

Keywords: PGE2, EP, functional dyspepsia, duodenal inflammation

Introduction

Functional dyspepsia (FD) is a common disease which presents with upper abdominal symptoms (e.g., abdominal pain and a heavy feeling in the stomach) despite the absence of organic disease.(1) Regarding the pathogenesis of FD, gastro­intestinal hypersensitivity and motor dysfunctions have been identified as the main causes of dyspeptic symptoms. However, the exact reason behind these physiological abnormalities in patients with FD remains unclear.(2) Recent studies have revealed that patients with functional gastrointestinal disorders have mucosal microinflammation, increased permeability, and altered intestinal microbiota in the mucosa of the gastrointestinal tract.(3) Microinflammation of the duodenum in FD, which is believed to be caused by eosinophil infiltration and mast cells, may be involved in the excitability of the duodenum to the irritating stimulant.(2,4) Recent data showed that irritation of the duodenum with acid or fat caused gastric visceromotor dysfunction in healthy humans.(57) However, it is unclear what occurs within the duodenal mucosa in response to irritating duodenal contents. Therefore, in this study, we tried to determine the mediator is associated with duodenal activation after irritant exposure.

Prostaglandin E2 (PGE2), a typical inflammatory mediator, is known to be more abundant than other prostaglandins in the gastrointestinal tract. The receptors activated by PGE2 have been pharmacologically classified into four types, EP1, EP2, EP3, and EP4.(8) PGE2 exhibits a great impact on pain signals,(9) while EP receptors are involved in peripheral hyperalgesic responses in the somatic pain region.(10) Regarding visceral perception, we previously reported that acid stimulation caused PGE2 production from human esophageal mucosal epithelium, which was associated with heartburn symptoms.(11) In the esophageal mucosa, EP1 receptors are abundantly located, and suppression of PGE2 using nonsteroidal anti-inflammatory drugs or administration of EP1 receptor antagonists partially suppressed these heartburn symptoms.(12,13) This suggests that the PGE2–EP1 pathway plays an important role in human esophageal perception to the acid. On the other hand, we recently reported that the release of PGE2 by activating TRPA1 channels promotes rectal colon contraction,(14) while the activation of EP3 receptors has been reported to regulate gastrointestinal motility.(15) These reports suggest association of PGE2 with gastrointestinal motility.

Thus, we speculated that PGE2 may be one of the mediators that are activated after irritating contents pass the duodenum, causing the physiological abnormalities of the stomach. Furthermore, the distribution of PGE2 and its relatives in the duodenum has almost never been explored. In line with this, we investigated whether acid stimulation of the duodenum in normal rats increased PGE2 levels as well as the presence and localization of PGE2 related receptors and its producing enzymes.

Materials and Methods

Duodenal acid infusion

This study used 7-week-old normal Sprague–Dawley (SD) rats. The abdomen was opened under adequate inhalation anesthesia. The anorectal side of the duodenum of the rats was ligated with a Kocher to avoid irritating the organ as much as possible. A 4-Fr catheter was then inserted and implanted from the gastric vestibule to the duodenal lumen, and 0.2 ml of pH 1.0 hydrochloric acid was administered from the tip of the catheter. The duodenal side was ligated using a Kocher simultaneously upon administration to create a closed space. Five minutes after the acid injection, the duodenum was excised and quickly placed in liquid nitrogen.

PGE2 concentration in the duodenum

The PGE2 concentration was measured in the rat duodenum as described previously.(11,12) In brief, the duodenum at the site of the closed space was excised, quickly frozen with liquid nitrogen. After measuring the weight of the duodenal tissue, homogenization (300 Hz/s, 3 min) was conducted with a mixer mill (MM300; QIAGEN, Hiden, Land Nordrhein-Westfalen, Germany). The protein concentration in the supernatant was measured with the BCATM protein assay kit (Thermo Fisher Scientific Inc, MA). The level of PGE2 was measured by enzyme-linked immuno­sorbent assay. To measure the amount of prostaglandin E2 (PGE2), EIA Kit-Monoclonal (Cayman Chemical Company, Ann Arbor, MI) was used according to the methods described in the manual. The concentration was determined following absorbance measurement with a microplate reader (SPECTRA MAX 250; Molecular Devices Japan Co., Tokyo, Japan). 0.2 ml saline was added instead of hydrochloric acid (HCl) as a comparison (saline group). The normal group was defined as the one in which the duodenum was removed under laparotomy without administering anything to the duodenum.

In situ hybridization histochemistry

In 7-week-old normal SD rats, the duodenum was opened under sufficient inhalational anesthesia, and, with as little irritation as possible, it was removed and promptly frozen with liquid nitrogen. The frozen duodenum was sectioned at 16 μm. The expression and distribution of mRNA encoding EP1, EP2, EP3, EP4, cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), two membrane-bound PGE synthases, microsomal PGE synthase (mPGES)-1, and mPGES-2, and cytosolic prostaglandin E synthase (cPGES) in the rat duodenum, were detected using a single in situ hybridization histochemistry (ISHH). ISHH was performed as described previously.(14,16) For ISHH, clones (pCRII-TOPO, Invitrogen Corp., Carlsbad, CA) containing a partial sequence corresponding to the coding regions of EP1, EP2, EP3, EP4, COX-1, COX-2, mPGES-1, and mPGES-2, and cPGES were prepared (Table 1). In brief, 35S-labeled RNA probes for PGE2 synthases and EP receptors were prepared by in vitro transcription using T7 or SP6 RNA polymerase. The 35S-labeled probes in the hybridization buffer were placed on the section and then incubated at 55°C overnight (>18 h). After the hybridization reaction, these sections were washed at 58°C in high-stringency buffer with 5 mM dithiothreitol (DTT) for 30 min, then treated with 1 μg/ml RNase A (Roche, Mannheim, Germany) in RNase buffer for 30 min at 37°C. Subsequently, these sections were incubated at 58°C in high-stringency buffer with 5 mM DTT for 30 min. Then, dehydrated through an ascending alcohol series, and air dried. The slides were coated with NTB emulsion (Kodak, Tokyo, Japan) and exposed for 2–4 weeks. After development in D19 and fixation in 24% sodium thiosulfate, the sections were rinsed in distilled water, stained with hematoxylin-eosin, dehydrated in a graded ethanol series, cleared in xylene and coverslipped.

Table 1.

Sequence location of primers

Gene Accession No. Forward Reverse
COX-1 U03388 1856–1875 2446–2427
COX-2 AF233596 1802–1821 2456–2437
mPGES-1 AB048730 25–44 453–434
mPGES-2 NM_001107832 854–873 1321–1302
cPGES BC166579 291–310 795–776
EP1 D88751 726–745 1320–1301
EP2 U94708 453–472 874–855
EP3 X83855 562–581 963–944
EP4 D28860 192–211 719–700

Statistical analysis

PGE2 levels before and after acid perfusions were compared between each group via two-way repeated analysis of variance followed by Bonferroni post hoc test. Data are presented as mean ± SE. Analyses were performed using JMP® 15 (SAS Institute Inc., Cary, NC). P<0.05 was considered to indicate statistical significance.

Results

PGE2 concentration in the duodenum

After acid perfusion into the duodenum, PGE2 levels (pg/mg protein) significantly increased compared to saline treatment rats (HCl, n = 14, 829.1 ± 76.4 vs saline, n = 14, 416.0 ± 71.9, p = 0.0004) (Fig. 1). There was no significant difference in PGE2 levels in both rats (saline, n = 14, 416.0 ± 71.9 vs normal, n = 8, 431.2 ± 95.2, p = 0.8994) in the saline and normal groups.

Fig. 1.

Fig. 1.

Changes in PGE2 expression after acid infusion in rat duodenum. The PGE2 levels (pg/mg protein) in the duodenum significantly increased in both rats in the hydrochloric acid (HCl) group compared to the saline group [saline (n = 14) vs HCl (n = 14), *p<0.005]. Data were presented as mean ± SE.

Localization of PGE2 synthase and EP receptors in rat duodenum

The expressions of EP1, EP2, EP3, EP4, COX-1, COX-2, mPGES-1, mPGES-2, and cPGES in the rat duodenum were investigated. Furthermore, in situ hybridization using the entire duodenum was performed to determine their localization. Thus, COX-1 mRNA was distributed throughout the muscular and mucosal layers of the duodenum (Fig. 2A–D), whereas COX-2 mRNA was distributed in the muscular layers, especially in the ringed muscle (Fig. 2E–G). Moreover, mPGES-1 mRNA was distributed in the submucosal tissue of the chorionic villi (Fig. 2H–J), mPGES-2 mRNA was predominantly distributed in the crypt epithelium (Fig. 2K–M), and cPGES mRNA was distributed throughout the muscular and in the crypt epithelium of the duodenum (Fig. 2N–Q). Next, EP1 mRNA-labeled cells were not clearly expressed in the duodenum (Fig. 3A–C), EP2 mRNA was mainly localized in the mucosa or tissues of the chorionic villi of the duodenum (Fig. 3D–F), EP3 mRNA was mainly localized in the myenteric plexus (Fig. 3G–I), and EP4 mRNA was in the tips of the chorionic epithelium, in the crypt epithelium and in the myenteric plexus (Fig. 3J–M).

Fig. 2.

Fig. 2.

COX-1, COX-2, cPGES, mPGES-1, and mPGES-2 mRNA in rat duodenal tissue. Arrowheads depict COX-1 (A–D), Cox-2 (E–G), mPges-1 (H–J), and mPGES-2 (K–M), and cPGES (N–Q) mRNA-positive cells. Dark field image (low-magnification: left) and bright field image (low-magnification: middle, high-magnification: right) showing ISHH products for EP receptors mRNA in the duodenum. Bright- and dark-field low-magnification images are the same field of view. Tissues were counterstained with hematoxylin for in situ hybridization.

Fig. 3.

Fig. 3.

EP1, EP2, EP3, and EP4 mRNA in rat duodenal tissue. Dark field image (low-magnification: left) and bright field image (low-magnification: middle, high-magnification: right) showing ISHH products for EP1 (A–C), EP2 (D–F), EP3 (G–I), and EP4 (J–M) receptors mRNA in the duodenum. Bright- and dark-field low-magnification images are the same field of view. Arrows depict mRNA-positive cells.

Discussion

The duodenal mucosa is exposed to various irritants, such as acid, dietary allergens (fats and amino acids, etc.), bile acids, and intestinal bacteria. Interestingly, recent data showed that irritation of the duodenum with acid or fat causes gastric visceromotor dysfunction in healthy humans.(57) In patients with FD, duodenal microinflammation and mucosal permeability have been reported, which may result in hypersusceptibility to irritating duodenal contents.(1719) Our recent study using a maternal deprivation rat model confirmed that duodenal microinflammation is closely associated with visceromotor dysfunction.(20) However, how such irritants activate the duodenum and cause visceromotor dysfunction remains unknown. Multiple speculations have been made regarding this; it is possible that irritants penetrate into the duodenal mucosa through intercellular spaces and stimulate nerve endings.(24) Besides the penetration theory, we hypothesized that the duodenal contents directly stimulate epithelial cells and produce the mediators from the mucosal cells, then excite the sensory nerves through the receptors on the duodenal mucosa. Prostaglandin is known to be one of the most famous and important chemical mediators and is located elsewhere in human body, and PGE2 is believed to deeply involved in the inflammation of gastrointestinal tract. Although role of PGE2 in the gastro­duodenal mucosa have been reported, most described the effect of PGE2 on mucosal protection or cytoprotection.(21,22) Therefore, present study focused on the relationship between FD and duodenal PGE2.

In human esophageal mucosa, PGE2 increment is mediated via the EP1 receptor, which plays an important role in the development of heartburn symptoms.(1113) As shown in this study, acid increased PGE2 levels in the duodenal mucosa, which could be mediated mainly by EP2, EP3, and EP4 receptors, but not EP1. The ISHH results in the current study showed that EP2 mRNA and EP4 mRNA were located in a relatively shallow layer, and that EP3 mRNA was located in relatively deeper layer, especially at the intermuscular plexus. In the present study, EP4 mRNA was found to be especially abundant in the epithelial surface area. PGE2/EP4 signaling is known to affect both epithelial and stromal cells, to regulate the intestinal immune system. Furthermore, the epithelial PGE2/EP4 axis plays a crucial role in maintaining colonic homeostasis and in suppressing the development of inflammation(23,24) and PGE2/EP2 signaling is known to be implicated in the gastric mucosal protective effect of capsaicin.(21) Thus, it is not surprising that EP2 and EP4 was mainly identified in the surface area.

Regarding the EP3 receptor, PGE2/EP3 is reported to be associated with the regulation of gastrointestinal motility.(15) Although its exact role is still unknown, it is interesting that EP3 receptors were abundantly seen at the intermuscular plexus. Together with the findings that COX-1 mRNA, COX-2 mRNA, and PG synthases mRNA were mainly observed in the deep duodenal mucosa, the role of prostaglandin for the regulation of visceromotor function might be largely dependent on the EP3 receptor. Identifying other PGE synthases, such as mPGES-1 and mPGES-2, could confirm that the role of PGE2 in the duodenal mucosa.

This study demonstrated the presence of PGE2 receptors and PG synthases in the duodenum. Acid, a representative duodenal irritant, was found to increase PGE2, which may play some roles via EP2, EP3, and EP4 receptors. Abundant EP3 receptors in the intermuscular plexus may especially imply the role of PGE2 in the pathophysiological mechanism for dyspeptic symptom generation. The investigation of PGE2 and its receptors in FD animal models and patients may address the question regarding the role of PGE2 in the pathophysiology of functional dyspepsia.

In conclusion, PGE2 levels in the duodenum increased following duodenal acidification. PGE2 receptors (EP2, EP3, and EP4) as well as PGE2 producing enzymes (mPGES-1, mPGES-2, cPGES, COX-1, and COX-2) were also observed in the rat duodenum. These observations suggest that duodenal PGE2 may play roles in the symptom generation of FD.

Author Contributions

TF and SD performed experiments, analyzed data, and drafted the manuscript; TKondo designed the research, analyzed data, and drafted the manuscript; HM designed the research, analyzed data, and edited the manuscript; KK and HY perform ISH, analyzed data and revised the manuscript. YF, TKonemura, and HO analyzed data and revised the manuscript; TKono, HK, MF, TT, TO, and HF interpreted data and revised the manuscript. YD and KN edited the manuscript. All authors contributed to the interpretation of data, revised it critically and approved the final version of the manuscript.

Abbreviations

COX

cyclooxygenase

cPGES

cytosolic prostaglandin E synthase

FD

functional dyspepsia

HCl

hydrochloric acid

mPGES-1

microsomal prostaglandin E synthase-1

mPGES-2

microsomal prostaglandin E synthase-2

PGE2

prostaglandin E2

Grant

This work was supported by JSPS KAKENHI Grant Number 18K08019.

Ethics Approval

All procedures involving the care and use of animals were approved by the Hyogo University of Health Sciences Committee on Animal Research (No. 2018-15-2).

Conflict of Interests

The authors have no conflict of interest. YF, TK, and HO is employee of Ono Pharmaceutical Co. Ltd.

This work was partially supported by the grant by Ono Pharmaceutical Co. Ltd.

References

  • 1.Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology 2016; 150: 1380–1392. [DOI] [PubMed] [Google Scholar]
  • 2.Miwa H, Oshima T, Tomita T, et al. Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center. J Gastroenterol 2019; 54: 305–311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014; 63: 262–271. [DOI] [PubMed] [Google Scholar]
  • 4.Talley NJ. Subdividing functional dyspepsia: a paradigm shift? Gut 2008; 57: 1487–1489. [DOI] [PubMed] [Google Scholar]
  • 5.Ishii M, Manabe N, Kusunoki H, et al. Real-time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy. J Gastroenterol 2008; 43: 935–941. [DOI] [PubMed] [Google Scholar]
  • 6.Lee KJ, Kim JH, Cho SW. Dyspeptic symptoms associated with hypersensitivity to gastric distension induced by duodenal acidification. J Gastroenterol Hepatol 2006; 21: 515–520. [DOI] [PubMed] [Google Scholar]
  • 7.di Stefano M, Vos R, Vanuytsel T, Janssens J, Tack J. Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers. Neurogastroenterol Motil 2009; 21: 712-e40. [DOI] [PubMed] [Google Scholar]
  • 8.Coleman RA, Kennedy I, Humphey PPA, Bunce K, Lumley P. Prostanoids and their receptors. In: Emmett JC, ed. Comprehensive Medicinal Chemistry Vol. 3: Membranes & Receptors, Oxford: Pergamon Press, 1990; 643–714. [Google Scholar]
  • 9.Kawabata A. Prostaglandin E2 and pain--an update. Biol Pharm Bull 2011; 34: 1170–1173. [DOI] [PubMed] [Google Scholar]
  • 10.Narumiya S, Furuyashiki T. Fever, inflammation, pain and beyond: prostanoid receptor research during these 25 years. FASEB J 2011; 25: 813–818. [DOI] [PubMed] [Google Scholar]
  • 11.Kondo T, Oshima T, Tomita T, et al. Prostaglandin E(2) mediates acid-induced heartburn in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2013; 304: G568–G573. [DOI] [PubMed] [Google Scholar]
  • 12.Kondo T, Oshima T, Tomita T, et al. The nonsteroidal anti-inflammatory drug diclofenac reduces acid-induced heartburn symptoms in healthy volunteers. Clin Gastroenterol Hepatol 2015; 13: 1249–1255.e1. [DOI] [PubMed] [Google Scholar]
  • 13.Kondo T, Sei H, Yamasaki T, et al. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol 2017; 52: 1081–1089. [DOI] [PubMed] [Google Scholar]
  • 14.Yang Y, Wang S, Kobayashi K, et al. TRPA1-expressing lamina propria mesenchymal cells regulate colonic motility. JCI Insight 2019; 4: e122402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kim MW, Jiao HY, Kim SW, et al. Prostanoid EP3 receptor agonist sulprostone enhances pacemaker activity of colonic interstitial cells of Cajal. Naunyn Schmiedebergs Arch Pharmacol 2017; 390: 961–969. [DOI] [PubMed] [Google Scholar]
  • 16.Kanda H, Kobayashi K, Yamanaka H, Okubo M, Dai Y, Noguchi K. Localization of prostaglandin E2 synthases and E-prostanoid receptors in the spinal cord in a rat model of neuropathic pain. Brain Res 2021; 1750: 147153. [DOI] [PubMed] [Google Scholar]
  • 17.Vanheel H, Farré R. Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 142–149. [DOI] [PubMed] [Google Scholar]
  • 18.Igarashi M, Nakae H, Matsuoka T, et al. Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastroenterol 2017; 4: e000144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Taki M, Oshima T, Li M, et al. Duodenal low-grade inflammation and expression of tight junction proteins in functional dyspepsia. Neurogastroenterol Motil 2019; 31: e13576. [DOI] [PubMed] [Google Scholar]
  • 20.Duan S, Kondo T, Miwa H, et al. Eosinophil-associated microinflammation in the gastroduodenal tract contributes to gastric hypersensitivity in a rat model of early-life adversity. Am J Physiol Gastrointest Liver Physiol 2021; 320: G206–G216. [DOI] [PubMed] [Google Scholar]
  • 21.Takeuchi K, Ukawa H, Kato S, et al. Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E-receptor subtype EP3. Gastroenterology 1999; 117: 1128–1135. [DOI] [PubMed] [Google Scholar]
  • 22.Takeuchi K. Gastric cytoprotection by prostaglandin E2 and prostacyclin: relationship to EP1 and IP receptors. J Physiol Pharmacol 2014; 65: 3–14. [PubMed] [Google Scholar]
  • 23.Matsumoto Y, Nakanishi Y, Yoshioka T, et al. Epithelial EP4 plays an essential role in maintaining homeostasis in colon. Sci Rep 2019; 9: 15244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002; 109: 883–893. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Biochemistry and Nutrition are provided here courtesy of The Society for Free Radical Research Japan

RESOURCES